Charles Schwab Investment Management Inc. Acquires 38,313 Shares of Liquidia Co. (NASDAQ:LQDA)

Charles Schwab Investment Management Inc. lifted its stake in Liquidia Co. (NASDAQ:LQDA) by 9.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 428,570 shares of the company’s stock after purchasing an additional 38,313 shares during the period. Charles Schwab Investment Management Inc. owned 0.51% of Liquidia worth $5,040,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of LQDA. Intech Investment Management LLC purchased a new stake in Liquidia in the third quarter worth about $195,000. BNP Paribas Financial Markets increased its holdings in Liquidia by 735.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 140,190 shares of the company’s stock worth $1,402,000 after acquiring an additional 123,402 shares in the last quarter. Acuta Capital Partners LLC bought a new stake in Liquidia during the 3rd quarter worth approximately $735,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Liquidia by 43.5% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,708 shares of the company’s stock worth $187,000 after acquiring an additional 5,669 shares during the period. Finally, Walleye Trading LLC lifted its holdings in Liquidia by 54.7% during the third quarter. Walleye Trading LLC now owns 13,201 shares of the company’s stock valued at $132,000 after purchasing an additional 4,670 shares in the last quarter. 64.54% of the stock is currently owned by hedge funds and other institutional investors.

Liquidia Stock Down 0.4 %

Shares of Liquidia stock opened at $15.60 on Wednesday. Liquidia Co. has a twelve month low of $8.26 and a twelve month high of $16.81. The business has a 50-day moving average price of $14.95 and a 200-day moving average price of $12.32. The firm has a market cap of $1.33 billion, a price-to-earnings ratio of -9.57 and a beta of 0.07.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings data on Wednesday, March 19th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.38) by ($0.08). The business had revenue of $2.92 million for the quarter, compared to the consensus estimate of $4.60 million. Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. On average, equities analysts expect that Liquidia Co. will post -1.51 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently commented on LQDA shares. Needham & Company LLC raised their price objective on shares of Liquidia from $19.00 to $25.00 and gave the company a “buy” rating in a research report on Thursday, March 20th. HC Wainwright reissued a “buy” rating and set a $29.00 price target on shares of Liquidia in a report on Thursday, March 20th. Scotiabank boosted their price objective on Liquidia from $30.00 to $34.00 and gave the company a “sector outperform” rating in a research report on Thursday, March 20th. Finally, Wells Fargo & Company assumed coverage on Liquidia in a research report on Friday, December 20th. They set an “overweight” rating and a $20.00 target price for the company. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $26.63.

Insider Activity

In other news, General Counsel Russell Schundler sold 16,393 shares of the company’s stock in a transaction dated Tuesday, January 14th. The shares were sold at an average price of $11.78, for a total value of $193,109.54. Following the transaction, the general counsel now directly owns 573,478 shares in the company, valued at approximately $6,755,570.84. This represents a 2.78 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Rajeev Saggar sold 2,445 shares of the company’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $13.00, for a total transaction of $31,785.00. Following the completion of the transaction, the insider now owns 267,943 shares in the company, valued at $3,483,259. This represents a 0.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 71,245 shares of company stock valued at $843,326. 30.10% of the stock is currently owned by insiders.

Liquidia Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).